NDC 60219-1420

Silodosin

Silodosin

Silodosin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Silodosin.

Product ID60219-1420_4c552785-6057-4319-8b96-e834d7c9bcd3
NDC60219-1420
Product TypeHuman Prescription Drug
Proprietary NameSilodosin
Generic NameSilodosin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2018-12-03
Marketing CategoryANDA /
Application NumberANDA209745
Labeler NameAmneal Pharmaceuticals NY LLC
Substance NameSILODOSIN
Active Ingredient Strength8 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 60219-1420-3

30 CAPSULE in 1 BOTTLE (60219-1420-3)
Marketing Start Date2018-12-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Silodosin" or generic name "Silodosin"

NDCBrand NameGeneric Name
0781-2623SilodosinSilodosin
0781-2624SilodosinSilodosin
27241-144SilodosinSilodosin
27241-145SilodosinSilodosin
31722-635SilodosinSilodosin
31722-636SilodosinSilodosin
33342-384SilodosinSilodosin
33342-385SilodosinSilodosin
42291-777SilodosinSilodosin
42291-778SilodosinSilodosin
46708-405SilodosinSilodosin
46708-406SilodosinSilodosin
59651-095SILODOSINSILODOSIN
59651-096SILODOSINSILODOSIN
68180-740SilodosinSilodosin
68180-741SilodosinSilodosin
69238-1421SilodosinSilodosin
69238-1420SilodosinSilodosin
69539-052SILODOSINSILODOSIN
69539-053SILODOSINSILODOSIN
72205-010SILODOSINSILODOSIN
72205-009SILODOSINSILODOSIN
62332-406SilodosinSilodosin
62332-405SilodosinSilodosin
72789-090SILODOSINSILODOSIN
0023-6142RAPAFLOsilodosin
0023-6147RAPAFLOsilodosin
52544-151RAPAFLOsilodosin
52544-152RAPAFLOsilodosin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.